65,437 trials
Deglutition Disorders
Primary: Pressure and Timing Change of Velopharynx, Tongue Base, Low Pharynx and Upper Esophageal Sphincter. — 162.04; 129.66; 200.90; 170.66 mmHg — p=< 0.05
End Stage Renal Disease
Primary: Anti-Xa Activity as Measured by the AUC (Area Under the Curve) 0-t — .798; .733 IU*hr/mL
Stress Urinary Incontinence
Primary: Number of Participants With a ≥ 50% Reduction From Baseline in the Mean Number of Stress Incontinence Episodes Per Day at Week 12 — 94; 96; 87 Participants
Narcolepsy With Cataplexy
Primary: Change in Weekly Number of Cataplexy Attacks — 0.00; 2.35 attacks
Class II Division 1 Malocclusion · Retrognathic Mandible
Primary: Total Mandibular Length (Co-Gn) — 3.51; 1.18 mm
MELAS · LHON · Leigh Syndrome
Primary: SAD: Change From Baseline in ECG Results by Timepoint: Corrected QT Interval According to Fridericia's Formula (QTcF) — 386.2; 395.0; 385.8; 399.3 msec
Telemedicine
Primary: Speech Perception on Monosyllabic Word Test, CNC Words — 70.5; 72.4; 72.5 percentage of words correct
Obstructive Sleep Apnea (OSA) · Post-Traumatic Stress Disorder (PTSD)
Primary: Adherence (Hours on Therapy) — 1.1; 0.5 Hours/night
Adverse Effect of MRI on an Implanted Pacemaker Lead · Adverse Effect of MRI on an Implanted Pacemaker
Primary: Freedom From Right Atrial (RA) Lead-related Complications in the Acute Period — 97.2 percentage of subjects
Acute Otitis Media · Mastoiditis
Primary: Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 — 5.9; 0.7; 31.9; 2.2 percentage of isolates
Multiple Myeloma
Primary: Progression Free Survival (PFS) — 9.4; 17.4 months
Premature Birth
Primary: Expiratory Tidal Volume — 153; 194 ml/kg/min
Hemophilia B
Primary: Number of Adverse Events (AEs) After the Administration of Investigational Products (IP) — 0; 10; 10; 69 adverse events
Ovarian Neoplasms Malignant (Excl Germ Cell) · Peritoneal Carcinoma · Fallopian Tube Cancer
Primary: Number of Participants With Dose-Limiting Toxicity (DLT) — 0; 0; 0; 0 Participants
Back Pain · Acute Pain · Back Spasm Upper Back
Primary: Mean Effect Size in Subjected-Rated Pain — -4.2; -4.0; -3.7; -4.4 score on a scale